Cargando…
Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516439/ https://www.ncbi.nlm.nih.gov/pubmed/37744348 http://dx.doi.org/10.3389/fimmu.2023.1284628 |
_version_ | 1785109128566276096 |
---|---|
author | Bodas-Pinedo, Andrés Lafuente, Esther M. Pelaez-Prestel, Hector F. Ras-Carmona, Alvaro Subiza, Jose L. Reche, Pedro A. |
author_facet | Bodas-Pinedo, Andrés Lafuente, Esther M. Pelaez-Prestel, Hector F. Ras-Carmona, Alvaro Subiza, Jose L. Reche, Pedro A. |
author_sort | Bodas-Pinedo, Andrés |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10516439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105164392023-09-23 Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus Bodas-Pinedo, Andrés Lafuente, Esther M. Pelaez-Prestel, Hector F. Ras-Carmona, Alvaro Subiza, Jose L. Reche, Pedro A. Front Immunol Immunology Frontiers Media S.A. 2023-09-08 /pmc/articles/PMC10516439/ /pubmed/37744348 http://dx.doi.org/10.3389/fimmu.2023.1284628 Text en Copyright © 2023 Bodas-Pinedo, Lafuente, Pelaez-Prestel, Ras-Carmona, Subiza and Reche https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Bodas-Pinedo, Andrés Lafuente, Esther M. Pelaez-Prestel, Hector F. Ras-Carmona, Alvaro Subiza, Jose L. Reche, Pedro A. Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus |
title | Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus |
title_full | Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus |
title_fullStr | Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus |
title_full_unstemmed | Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus |
title_short | Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus |
title_sort | corrigendum: combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza a virus |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516439/ https://www.ncbi.nlm.nih.gov/pubmed/37744348 http://dx.doi.org/10.3389/fimmu.2023.1284628 |
work_keys_str_mv | AT bodaspinedoandres corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus AT lafuenteestherm corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus AT pelaezprestelhectorf corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus AT rascarmonaalvaro corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus AT subizajosel corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus AT rechepedroa corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus |